ArticleScientific reports2024

Comprehensive analyses of solute carrier family members identify SLC12A2 as a novel therapy target for colorectal cancer.

Dan-Yang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.